pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·16h ago·1 min read
save

Singapore opens biotech-focused Boston hub, strengthening ties with city

Sep 10, 2026·read at Fierce Biotech ↗Positive

Singapore announced the opening of its fifth U.S. overseas centre, a biotech-focused hub in Boston, during an event at the historic Raffles Hotel. Government officials and business leaders gathered to mark the milestone and to highlight the long-standing relationship between the two regions.

The new centre is situated in Kendall Square, Cambridge, and has been operating for almost a year. At the ceremony, Singapore and the host U.S. state signed their first agreement aimed at fostering mutual economic growth in the biotech sector.

Boston Mayor Michelle Wu attended the launch and expressed confidence in the partnership, saying the Kendall Square hub will soon become Singapore's premier American office.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'”

read at Fierce Biotech ↗
1,082 words · retrieved 30m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
OVERSEAS5NOVARTIS
topics
AMDCRO/CDMOCell Therapy

related stories

  • 1d agoMerck adds 53 to New Jersey chopping blockBioSpace
  • Sep 3The hidden scale-out problem behind CAR-T’s growthBioPharma Dive
  • Aug 14After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?Fierce Biotech
  • Dec 22Fierce Biotech Fundraising Tracker '26: Encoded finagles $275M series F; Solstice rises with $225MFierce Biotech
  • May 13FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive